Skip to main content
Premium Trial:

Request an Annual Quote

Broad Institute to Use Fluidigm Access Array for Targeted Resequencing

Premium

This article was originally published on May 25.

Fluidigm said today that the Broad Institute has purchased an Access Array system to automate sample prep for targeted resequencing.

Access Array enhances the capabilities of next-generation sequencing platforms by allowing the preparation of several sample libraries in parallel, Fluidigm said. The multiplexed system enables parallel amplification of 48 samples — the equivalent of 48 sequencing libraries — in a few hours, according to the company.

The system is used for target enrichment, sample barcoding for multiplexed sequencing, and sequencing library preparation using amplicon tagging; and can be used with any PCR-based sample preparation method with reagents and primers of the customer’s choosing, the company said.

Access Array includes the company's specific single-use microfluidic Integrated Fluidic Circuits, two IFC Controllers, and a standalone thermal cycler.

Financial details were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.